Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study

Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study - Immunological and histological profiles in peripheral-blood and tumor-infiltrating immune cells and immune-related factors through overall treatment time in patients with renal cell carcinoma: an exploratory study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031936

Enrollment

Registered

2018-03-28

Start date

2018-10-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with metastatic or locally-advanced renal cell carcinoma who receive resection of the primary and/or metastatic lesions and systemic drug therapy

Exclusion criteria

Exclusion criteria: Patients receiving any anti-cancer drug for other malignancy Patients receiving any systemic immune-suppressive therapy Patients judged as unsuitable by their attending physician

Design outcomes

Primary

Measure	Time frame
The profile of immune cells in peripheral blood and tumor tissue	—

Secondary

Measure	Time frame
The profile of immune-related cytokines in serum The expression of tumor-infiltrating lymphocytes and immune-related molecules in tumor tissue	—

Countries

Japan

Contacts

Public ContactMasahiro Nozawa

Kindai University Faculty of Medicine Department of Urology

nozawa06@med.kindai.ac.jp072-366-0221

Outcome results